Nymox Pharmaceutical Corp
NYMXF- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001018735
No open-market purchases or sales by Nymox Pharmaceutical Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.21K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Nymox Pharmaceutical Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −12 vs. Q2 2021
- Shares held
- 1.94M
- −577.0K (−22.9%) vs. Q2 2021
- Total value
- $4.00M
- +$19.8K (+0.5%) vs. Q2 2021
- New holders
- 1
- 6 more added
- Sold out
- 13
- 16 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYMXF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4.21K |
| Q1 2026 | 1 | $2.46K |
| Q4 2025 | 1 | $1.41K |
| Q3 2025 | 1 | $2.06K |
| Q2 2025 | 1 | $4.13K |
| Q1 2025 | 2 | $16.0K |
| Q4 2024 | 1 | $3.51K |
| Q3 2024 | 2 | $13.2K |
| Q2 2024 | 1 | $6.67K |
| Q1 2024 | 3 | $48.0K |
| Q4 2023 | 2 | $26.6K |
| Q3 2023 | 5 | $68.3K |
| Q2 2023 | 36 | $287.4K |
| Q1 2023 | 35 | $575.1K |
| Q4 2022 | 37 | $443.7K |
| Q3 2022 | 34 | $494.6K |
| Q2 2022 | 39 | $590.1K |
| Q1 2022 | 40 | $2.25M |
| Q4 2021 | 43 | $2.05M |
| Q3 2021 | 38 | $4.00M |
| Q2 2021 | 51 | $4.03M |
| Q1 2021 | 59 | $13.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Nymox Pharmaceutical Corp; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federation des caisses Desjardins du Quebec | 521,000 | $1.07M | 0.01% | −20,050−3.7% | Reduced |
| Ergoteles LLC | 184,933 | $381.0K | 0.01% | −1,277−0.7% | Reduced |
| Private Advisor Group, LLC | 170,200 | $350.0K | 0.00% | +139,100+447.3% | Added |
| BlackRock Inc. | 137,668 | $283.0K | 0.00% | −21,997−13.8% | Reduced |
| HRT Financial LP | 114,635 | $236.0K | 0.00% | −5,531−4.6% | Reduced |
| Susquehanna International Group, LLP | 90,039 | $185.0K | 0.00% | +55,077+157.5% | Added |
| Webster Bank, N. A. | 80,000 | $165.0K | 0.02% | 00.0% | Unchanged |
| Leonteq Securities AG | 79,997 | $164.8K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 70,617 | $145.0K | 0.00% | −5,622−7.4% | Reduced |
| Millennium Management LLC | 68,623 | $141.0K | 0.00% | −254,741−78.8% | Reduced |
| Geode Capital Management, LLC | 50,731 | $104.0K | 0.00% | +9,086+21.8% | Added |
| First Citizens Financial Corp | 35,100 | $72.0K | 0.06% | 00.0% | Unchanged |
| Patriot Financial Group Insurance Agency, LLC | 31,400 | $65.0K | 0.01% | −13,250−29.7% | Reduced |
| Credit Suisse AG | 30,014 | $62.0K | 0.00% | −1,692−5.3% | Reduced |
| Brown Advisory Securities, LLC | 28,000 | $58.0K | 0.02% | 00.0% | Unchanged |
| Gofen & Glossberg LLC | 25,000 | $52.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 24,381 | $50.0K | 0.00% | −24,355−50.0% | Reduced |
| Willow Creek Wealth Management Inc. | 24,224 | $50.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 22,283 | $46.0K | 0.00% | −7,664−25.6% | Reduced |
| Group One Trading, L.P. | 22,029 | $45.0K | 0.00% | +18,098+460.4% | Added |
| Brown Advisory Inc | 18,700 | $39.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 13,500 | $28.0K | 0.00% | 00.0% | Unchanged |
| Cubic Asset Management, LLC | 13,100 | $27.0K | 0.01% | +250+1.9% | Added |
| JPMorgan Chase & Co | 12,180 | $25.0K | 0.00% | −24,832−67.1% | Reduced |
| Advisor Group Holdings, Inc. | 12,100 | $25.0K | 0.00% | +9,500+365.4% | Added |
| Kestra Advisory Services, LLC | 11,532 | $24.0K | 0.00% | 00.0% | Unchanged |
| One Day In July LLC | 10,000 | $21.0K | 0.01% | 00.0% | Unchanged |
| Wells Fargo & Company | 7,478 | $15.0K | 0.00% | 00.0% | Unchanged |
| Optiver Holding B.V. | 6,109 | $13.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 7,378 | $11.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 5,046 | $10.0K | 0.00% | −3,861−43.3% | Reduced |
| UBS Group AG | 3,333 | $7.00K | 0.00% | −1,889−36.2% | Reduced |
| PSI Advisors, LLC | 3,000 | $6.00K | 0.00% | +3,000 | New |
| Newbridge Financial Services Group, Inc. | 2,500 | $5.00K | 0.00% | −10,500−80.8% | Reduced |
| Sterling Investment Advisors, Ltd. | 2,500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 2,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,697 | $3.50K | 0.00% | −500−22.8% | Reduced |
| Royal Bank of Canada | 167 | $0 | 0.00% | −8,662−98.1% | Reduced |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −151,100−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −73,781−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −42,251−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −36,265−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −33,665−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −30,494−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −17,431−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −10,391−100.0% | Sold out |
| BDO Wealth Advisors, LLC | 0 | $0 | 0.00% | −4,700−100.0% | Sold out |
| Sonora Investment Management, LLC | 0 | $0 | 0.00% | −3,800−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −332−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −194−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −316−100.0% | Sold out |
| Geier Asset Management, Inc. | – | – | – | – | Not filed |